Summary: Biologic development is complex, requiring a significant amount of time and resources to ensure the best chance of success. Consequently, there are numerous aspects...

Summary: Biopharmaceutical products in development continue to increase in complexity. These include numerous multi-specific antibody platforms, proteins that require cleavage, or other additional post-translational modifications...

Summary: There are multiple opportunities for companies to speed time to clinic, which impacts the speed to...

Summary: A new wave of biologics in the clinic has forced companies to rethink how they execute Phase I studies. In this webinar, a panel of...

Summary: Biologic drug development is complex, requiring broad capabilities and expertise to ensure the highest likelihood of regulatory approval and...

Summary: Developing and bringing a new drug to market is a long, expensive, and uncertain process. It’s even more complicated when it comes to complex products...

Summary: There are many challenges to conduct thorough drug product formulation development at early stage drug substance process development. Those challenges include...

Summary: Contract development and manufacturing organizations (CDMOs) occupy a unique position in the pharmaceutical industry. They have the great opportunity of being able to...

Summary: Pharma companies are looking for ways to speed up their biologics to market in order to meet the patients' needs. During this webinar...

Summary: Watch this webinar to see an overview and case study of process characterization performed by Catalent...